SS Innovations International, Inc. reported significant financial growth in its latest quarterly filing, with total revenue reaching $12.8 million for the three months ending September 30, 2025, compared to $4.4 million for the same period in 2024. This 192% increase was driven primarily by a rise in system sales, which accounted for $11.7 million, up from $4.0 million year-over-year. The company also noted a gross profit of $6.2 million, reflecting a substantial improvement from $2.3 million in the prior year, attributed to lower raw material costs and enhanced manufacturing efficiencies.
In terms of operational performance, SS Innovations sold 28 surgical robotic systems during the third quarter of 2025, contributing to a total of 55 systems sold in the first nine months of the year. The company has also expanded its geographic footprint, with 94% of its revenue coming from India, while international sales accounted for the remaining 6%. The company’s total assets increased to $69.6 million as of September 30, 2025, up from $42.4 million at the end of 2024, largely due to increased cash reserves and inventory levels.
Despite the revenue growth, SS Innovations reported a net loss of $3.7 million for the third quarter, slightly higher than the $3.2 million loss recorded in the same quarter of the previous year. The increase in losses was primarily due to higher selling, general, and administrative expenses, which rose to $4.8 million from $2.5 million, driven by increased legal and marketing costs associated with the company's recent uplisting to NASDAQ. Additionally, the company recognized an income tax expense of $1.8 million, marking its first tax obligation as its Indian operations became profitable.
The company has been actively raising capital to support its growth, securing $28 million through convertible notes from its principal stockholder, Sushruta Pvt Ltd., in early 2025. This funding is crucial as SS Innovations continues to invest in research and development, with R&D expenses totaling $786,319 for the quarter, up from $442,839 a year earlier. The company is focused on enhancing its surgical robotic systems and expanding its product offerings, which it believes will further drive revenue growth.
Looking ahead, SS Innovations remains optimistic about its growth trajectory, although it acknowledges the need for additional funding to sustain operations and support expansion plans. The management is actively pursuing further capital raises and is committed to improving its operational efficiencies to achieve profitability in the future. The company’s ability to navigate these challenges will be critical as it continues to establish itself in the competitive surgical robotics market.
About SS Innovations International, Inc.
SS Innovations International, Inc. designs and markets affordable surgical robotic systems, primarily the SSi Mantra, to improve minimally invasive surgeries across diverse medical fields. Focused on underserved markets like India, it aims to expand globally through direct sales and distributor networks. The company emphasizes innovation, surgeon training, and remote telesurgery, offering cost-effective solutions that enhance patient outcomes and operational efficiency.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.